| SpectraBase Spectrum ID |
8H1dWs7cqLQ |
| Name |
1-(2-Chlorobenzyl)-4-(2-hydroxyethyl)piperazine |
| Classification |
Piperazine designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
254.118590939 u |
| Formula |
C13H19ClN2O |
| InChI |
InChI=1S/C13H19ClN2O/c14-13-4-2-1-3-12(13)11-16-7-5-15(6-8-16)9-10-17/h1-4,17H,5-11H2 |
| InChIKey |
PGCGYLAMXVYWQH-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
254.761 g/mol |
| Nominal Mass |
254 u |
| Quality |
955 |
| Retention Index |
1970 |
| SMILES |
OCCN1CCN(CC=2C(=CC=CC2)Cl)CC1 |
| SPLASH |
splash10-00fr-9770000000-5a3c598d593ed7dfbc0b |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Piperazine,1-(2-chlorobenzyl)-4-(2-hydroxyethyl)
2-(4-(2-chlorobenzyl)piperazin-1-yl)ethan-1-ol |
| Technique |
GC/MS |
| Wiley ID |
DD2024_011243 |
